Haemodialysis Vascular Access: Recent Trends From ANZDATA Dr Kevan Polkinghorne Monash Medical Centre ANZSN September 2007.

Slides:



Advertisements
Similar presentations
When Using DOPPS Slides. DOPPS Slide Use Guidelines.
Advertisements

UK Renal Registry 16th Annual Report Figure Data completeness for key variables, stratified by first modality HD = haemodialysis; PD = peritoneal.
Dialysis vs Transplant: the Australia & New Zealand experience Stephen McDonald ANZDATA Registry Adelaide, South Australia.
UK Renal Registry 17th Annual Report Figure Data completeness for key variables, stratified by first modality DOB = date of birth; PRD = primary.
End Stage Kidney Disease Treatment Modalities Australia New Zealand Dec 2012 Prepared by Debbie Fortnum Kidney Health Australia Data courtesy of ANZDATA.
Chapter 3: Clinical Indicators and Preventive Care 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 2: Identification and Care of Patients With CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand ANZDATA Registry Annual Report Chapter 12.
Rowan Walker – Chairman Chair: Steve Chadban ANZDATA update (Stephen McDonald) Analgaesic nephropathy – the end of an epidemic? (Sean Chang)
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
Allocation of deceased donor kidneys Phil Clayton NSW Renal Group 14 June 2012.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
1 Influence of donor & recipient risk factors and the choice of immunosuppression Long term outcome after renal transplantation Influence of donor & recipient.
Why don’t indigenous dialysis patients receive transplants – waitlist or allocation? N. Khanal 1, P. Clayton 1, S. McDonald 1, M. Jose 2 1 The University.
Data completeness reporting Alex Hodsman, David Bull, Paul Dawson UK Renal Registry.
Kevan Polkinghorne Aarti Gulyani Stephen McDonald Kylie Hurst CHAPTER 5 HAEMODIALYSIS (including home haemodialysis) 2012 Annual Report—35th Edition ANZDATA.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PAEDIATRIC CHAPTER 11.
ANZDATA Registry Overview Dr Graeme Russ Darwin September 2001 September 2001.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
USRDS 1998 II , ,515 74,116 51,762 Period Prev. Point Prev. Incidence Deaths LFU** Counts (1000s) Year *Preliminary **Lost-to-Followup Reported.
Chapter 10 Cancer 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Cancer Working.
Chapter 12 End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.
Chapter 3 Mortality in End Stage Kidney Disease 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
Chapter 6 Home Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
Chapter 2: Identification and Care of Patients With CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
© ANZDATA Registry Prevalence and Incidence End Stage Renal Failure - Australia ( ) Per Million Functioning Transplant (259) New Pts (82) Deaths.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 10: Dialysis Providers.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 5: Hospitalization.
Generalitat de Catalunya Departament de Salut MORTALITY RISK FACTORS FOR THE FIRST YEAR OF HAEMODIALYSIS IN CATALONIA J. M. Mauri 1, M. Clèries.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 4: Vascular Access.
END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition DEATHS CHAPTER 3.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Similar Outcomes With Hemodialysis and Peritoneal.
Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.
Introduction Data Statistical Methods Table 1: Prevalence of Prior Hip Fracture and Incidence of New Hip Fractures and Fractures of Any Type.
When Using DOPPS Slides. DOPPS Slide Use Guidelines.
USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.
Obesity in the end stage kidney disease population
END-STAGE KIDNEY DISEASE AMONG 2013 Annual Report - 36th Edition
2016 Annual Data Report, Vol 2, ESRD, Ch 6
ASSOCIATION OF SOCIO-ECONOMIC POSITION WITH TECHNIQUE FAILURE AND MORTALITY IN AUSTRALIAN NON-INDIGENOUS PERITONEAL DIALYSIS PATIENTS Dr Samuel Chan Nephrology.
First-year death rates by modality figure 8
UK Renal Registry 10th Annual Report 2007
Patient populations by study group figure 10
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
Volume 2: End-Stage Renal Disease
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
UK Renal Registry 18th Annual Report
2016 Annual Data Report, Vol 2, ESRD, Ch 4
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients  Jiacong Luo, MD, MS, MPH, Donna E.
Volume 64, Issue 3, Pages (September 2003)
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
Fig 6.1 Frequency of ischaemic heart disease in incident patients
Type of vascular access and mortality in U.S. hemodialysis patients
UK Renal Registry 14th Annual Report
Stephen P. McDonald  Kidney International Supplements 
2013 Annual Report - 36th Edition
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
David A. Goodkin, MD, Eric W
Volume 82, Issue 3, Pages (August 2012)
Volume 61, Issue 1, Pages (January 2002)
Update from the Haemodialysis Working Group
Dialysis outcomes in Australia & New Zealand
ANZDATA: Vascular Access
Survival among hemodialysis patients by geographic region in DOPPS 3 (2005–2008), with and without adjustments for patient mix differences. Survival among.
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES
Presentation transcript:

Haemodialysis Vascular Access: Recent Trends From ANZDATA Dr Kevan Polkinghorne Monash Medical Centre ANZSN September 2007

Vascular Access: ANZDATA Vascular access type is an important indicator of quality of care in haemodialysis Collection of vascular access data by ANZDATA commenced in 1999: –Initially access in use at the end of survey period collected –31 st Oct 2003 – Access at first haemodialysis added Now 6+ years of data available for analysis enabling assessment of trends in vascular access use in the “guidelines era”

International trends Significant changes in vascular access practice patterns seen in US and Europe –USRDS –DOPPS

Graft As First Access Incident Hemodialysis USRDS USRDS Annual Report 2006

Fistula As First Access Incident Hemodialysis USRDS USRDS Annual Report 2006

Catheter As First Access Incident Hemodialysis USRDS USRDS Annual Report 2006

Moist L, Chang S, Polkinghorne K, McDonald S. In Press Am J Kidney Diseases Aims & Methods Key Questions: Are the recent trends in international catheter rates seen in ANZDATA? What are the characteristics of incident patients who use catheters?

Moist L, Chang S, Polkinghorne K, McDonald S. In Press Am J Kidney Diseases Trends in Incident Vascular Access: ANZDATA (1) Incident Cohort:Patients who commenced dialysis within 60 days of the survey period 2000, 2002, & 2004 (2) 6-8 Month Cohort:Patients on dialysis 6-8 months after commencement 2000, 2001, 2002, & 2003 (3) Prevalent Cohort:All patients on haemodialysis 2000, 2002, 2004, & 2005

Moist L, Chang S, Polkinghorne K, McDonald S. In Press Am J Kidney Diseases

Vascular Access: Incident Cohort

Unadjusted & Adjusted Incident Rates: Incident Cohort *p< 0.05 compared to 2000 Adjusted for age, sex, race, body mass index, late referral, smoking status, etiology of end stage renal disease, history of diabetes, coronary artery disease, peripheral vascular disease, cerebrovascular disease and hypertension

Vascular Access Use 6-8 Months After Starting Dialysis Moist L, Chang S, Polkinghorne K, McDonald S. In Press Am J Kidney Diseases

Unadjusted & Adjusted Incident Rates: 6-8 Months After Starting Dialysis *p< 0.05 compared to 2000 Adjusted for age, sex, race, body mass index, late referral, smoking status, etiology of end stage renal disease, history of diabetes, coronary artery disease, peripheral vascular disease, cerebrovascular disease and hypertension

Actual Vascular Access at First Haemodialysis Moist L, Chang S, Polkinghorne K, McDonald S. In Press Am J Kidney Diseases

Prevalent Vascular Access Moist L, Chang S, Polkinghorne K, McDonald S. In Press Am J Kidney Diseases

2006 Data

Conclusions Catheter rates have increased significantly over the last 6 years Rates increased not just in incident patients but also prevalence patients Increased rates not accounted for by differences in comorbidity Trends has continued into 2006 and “similar for PD and HDx units”

Acknowledgements Dr Louise Moist Dr Stephen MacDonald Dr Sean Chang ANZDATA Registry Renal Units in Australia and New Zealand